Navigation Links
Leerink in Medical News

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20 in New York. Dr. Hung will pr...

Caliper Life Sciences to Present at Leerink Swann's 3rd Annual Life Science Tools Roundtable Conference

HOPKINTON, Mass., July 31 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced that its presentation at the Leerink Swann's Life Science Tools Roundtable Conference in Boston, Massachusetts, will be webcast on Thursday, August 7 at 12:50 p.m. EDT. Kevin Hrusov...

Genomic Health to Participate in Leerink Swann Roundtable Conference

REDWOOD CITY, Calif., March 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that Steven Shak, M.D., Genomic Health's Chief Medical Officer, will participate in Leerink Swann's Roundtable Conference, Bugs and Drugs: The Future of Molecular Diagnostics, in New ...

Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Leerink Swann "Bugs and Drugs: The Future of Molecular Diagnostics Roundtable Conference" in New York on April 3, 2008 at approximately 1:20 p.m. Eastern T...

BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference

FRANKLIN LAKES, N.J., March 26 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it would present at the Leerink Swann Molecular Diagnostics Roundtable Conference on Thursday, April 3, 2008 at 10:10 a.m. (ET). ...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...2009, subject to satisfaction of customary closing conditions. Deutsche Bank Securities Inc. is acting as Sole Book-Running Manager for the offering. leerink Swann LLC is acting as Co-Lead Manager and Wedbush PacGrow Life Sciences is acting as Co-Manager. MAP Pharmaceuticals has filed a registration ...

Orexigen(R) Therapeutics Prices Public Offering of Common Stock

...t to satisfaction of customary closing conditions. leerink Swann LLC is acting as sole book-running manager f...ies of which may be obtained, when available, from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock

.... All of the shares are being offered by Orexigen. leerink Swann LLC is acting as sole book-running manager f...tus relating to this offering may be obtained from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes

...vestment Bank, Goldman, Sachs & Co. and Banc of America Securities LLC will act as joint book-running managers for the offering. Canaccord Adams, leerink Swann and Stifel Nicolaus will serve as co-managers. The offering will be made under Inverness' shelf registration statement on Form S-3 filed wi...

Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation

...g to the business, other intangibles, inventories and fixed assets. The closing of the transaction is subject to customary closing conditions. leerink Swann LLC acted as exclusive financial advisor and delivered an opinion to the board of Alsius as to the fairness of the transaction. William W...
Leerink in Medical Technology

Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 3, 2007 - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection Company(TM), announced today the publication of new preclinical data from additional confirmatory animal studies showing that Allon's product candidate AL-108 significantly reduces th...

Light Sciences Oncology Raises $40.1 Million in Series C Financing

... combined with our substantial cash reserves will allow us to continue to move forward with all aspects of our development plan in a timely manner." leerink Swann LLC acted as exclusive placement agent and exclusive financial advisor in connection with the transaction. About Light Sciences Oncology Lig...
Leerink in Biological Technology

Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference

SOUTH SAN FRANCISCO, Calif., May 13 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presid...

Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference

HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on Frida...

Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference

WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Con...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...d Exchange Commission a prospectus supplement with respect to the offering. leerink Swann LLC is acting as sole book-running manager for the offering. ...pplement and accompanying prospectus may be obtained, when available, from leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37(th) Floo...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

...and commissions and estimated expenses). leerink Swann LLC acted as sole book-running manager for t...g prospectus, copies of which may be obtained from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

...20 a.m. ET Deutsche Bank Securities 34th Annual Healthcare Conference InterContinental Boston Tuesday, May 19, 2009 4:35 p.m. ET leerink Swann Novel Cancer Therapeutics: Oncology Roundtable The Roosevelt Hotel, New York City Wednesday, May 20, 2009 10:30 a.m. ET The ...

Dendreon Reports First Quarter 2009 Financial Results

...of America / Merrill Lynch 2009 Health Care Conference on May 12, 2009 Deutsche Bank 34th Annual Healthcare Conference on May 19, 2009 leerink Swann Novel Cancer Therapeutics: Roundtable Conference on May 20, 2009 About Dendreon Dendreon Corporation is a biotechnolog...

Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

...before deducting the placement agent's fee and estimated offering expenses. leerink Swann LLC served as sole placement agent for the offering. Trout Capital pr... may be obtained at the SEC's website at http://www.sec.gov or by calling leerink Swann, toll free, at 1-800-808-7525, Ext. 4556. About Pharmasset P...

Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering

...lose on or about July 21, 2008, subject to satisfaction of customary closing conditions. Lazard Capital Markets LLC served as lead placement agent and leerink Swann LLC served as co-placement agent for the offering. Jazz Pharmaceuticals intends to use the net proceeds from this offering primarily to fund c...
Other Tags
(Date:7/14/2014)... Sunrise, FL (PRWEB) July 14, 2014 ... announced the expansion of its Quality Control and Assurance ... Formulations has hired two additional, highly-qualified quality assurance (QA) ... superior product standards for which IQ Formulations has become ... and QC technicians bring decades of stellar experience and ...
(Date:7/14/2014)... 2014 Secure Decisions, a leading provider ... with the Software Assurance Marketplace (SWAMP) to build a ... that drives everyday life. , The SWAMP, implemented by ... the Morgridge Institute for Research, is funded by the ... security practices by building a free facility with a ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... 14, 2014 Follow ... liquid chromatography or UPLC is a new ... chromatography that involves the use of extremely ... separate chromatographic compounds. This highly sensitive qualitative ... and analysis of chromatography samples. UPLC functions ...
(Date:7/14/2014)... Francisco, California (PRWEB) July 14, 2014 ... expected to reach USD 4,285.1 million by 2020 ... a new study by Grand View Research, Inc. ... computational biology for bioinformatics R&D programs designed for ... increasing number of clinical studies in pharmacogenomics and ...
Breaking Medicine News(10 mins):Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6
(Date:7/13/2014)... Ohio A new study in women suggests that ... eating a single high-fat meal can slow the body,s ... study participants about the previous day,s stressors before giving ... grams of fat. The scientists then measured their metabolic ... burn calories and fat and took measures of ...
(Date:7/11/2014)... Conservation Society shows that no-take zones in Belize ... as lobster, conch, and fish recover from overfishing, ... , The reporttitled "Review of the Benefits of ... from no-take areas around the world. The report ... expert in marine protected areas and fisheries management. ...
(Date:7/11/2014)... the City of Entiat on Tuesday, July 8, 2014. ... grew to over 1,000 acres by evening. Three outbuildings ... investigation by the Washington Department of Natural Resources. The ... in developing fire control strategies and tactics. Other cooperators ... of Natural Resources, (WA DNR), Bureau of Land Management, ...
Breaking Biology News(10 mins):Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4Belize's lobster, conch, and fish populations rebuild in no-take zones 2
Other Contents